Ex vivo biomechanical, functional, and immunohistochemical alterations of adrenergic responses in the female urethra in a rat model of birth trauma.
Birth trauma and pelvic injury have been implicated in the etiology of stress urinary incontinence (SUI). This study aimed to assess changes in the biomechanical properties and adrenergic-evoked contractile responses of the rat urethra after simulated birth trauma induced by vaginal distension (VD). Urethras were isolated 4 days after VD and evaluated in our established ex vivo urethral testing system that utilized a laser micrometer to measure the urethral outer diameter at proximal, middle, and distal positions. Segments were precontracted with phenylephrine (PE) and then exposed to intralumenal static pressures ranging from 0 to 20 mmHg to measure urethral compliance. After active assessment, the urethra was rendered passive with EDTA and assessed. Pressure and diameter measurements were recorded via computer. Urethral thickness was measured histologically to calculate circumferential stress-strain response and functional contraction ratio (FCR), a measure of smooth muscle activity. VD proximal urethras exhibited a significantly increased response to PE compared with that in controls. Conversely, proximal VD urethras had significantly decreased circumferential stress and FCR values in the presence of PE, suggesting that VD reduced the ability of the proximal segment to maintain smooth muscle tone at higher pressures and strains. Circumferential stress values for VD middle urethral segments were significantly higher than control values. Histological analyses using antibodies against general (protein gene product 9.5) and sympathetic (tyrosine hydroxylase) nerve markers showed a significant reduction in nerve density in VD proximal and middle urethral segments. These results strongly suggest that VD damages adrenergic nerves and alters adrenergic responses of proximal and middle urethral smooth muscle. Defects in urethral storage mechanisms, involving changes in adrenergic regulation, may contribute to stress urinary incontinence induced by simulated birth trauma.
Prantil-Baun
Rachelle
R
Department of Bioengineering, University of Pittsburgh, Pennsylvania, USA.
de Groat
William C
WC
Miyazato
Minoru
M
Chancellor
Michael B
MB
Yoshimura
Naoki
N
Vorp
David A
DA
D000320:Adrenergic Fibers / Q000187:drug effects* / Q000473:pathology; D058646:Adrenergic alpha-1 Receptor Agonists; D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000818:Animals; D003187:Compliance; D004195:Disease Models, Animal; D005260:Female; D007834:Lasers; D042282:Microdissection / Q000295:instrumentation; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000293:injuries / Q000294:innervation* / Q000473:pathology; D036801:Parturition; D010656:Phenylephrine / Q000494:pharmacology*; D011247:Pregnancy; D011312:Pressure; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors; D014521:Urethra / Q000293:injuries / Q000294:innervation* / Q000473:pathology; D014549:Urinary Incontinence / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology
D058646:Adrenergic alpha-1 Receptor Agonists; D000316:Adrenergic alpha-Agonists; D010656:Phenylephrine
J Pharmacol Exp Ther. 1999 Dec;291(3):925-31
10565807
J Pharmacol Exp Ther. 2004 Mar;308(3):797-804
14718592
Am J Physiol Renal Physiol. 2004 Feb;286(2):F225-32
14506075
J Investig Dermatol Symp Proc. 2001 Nov;6(1):115-21
11764279
Urology. 1998 Jul;52(1):143-51
9671889
Circ Res. 1979 Mar;44(3):420-9
104801
Am J Physiol Renal Physiol. 2007 Apr;292(4):F1229-37
17190909
Auton Autacoid Pharmacol. 2006 Oct;26(4):345-53
16968473
Eur Urol. 2010 Mar;57(3):506-12
19346061
Br J Urol. 1973 Dec;45(6):621-30
4798090
J Womens Health (Larchmt). 2005 Sep;14(7):595-608
16181016
J Urol. 2002 Jul;168(1):323-30
12050564
Rev Urol. 2004;6 Suppl 5:S11-7
16985903
BJU Int. 2002 Sep;90(4):403-7
12175397
Br J Pharmacol. 1997 Apr;120(7):1229-40
9105697
Urol Int. 2002;69(1):36-41
12119437
Acta Obstet Gynecol Scand. 1998 Jan;77(1):95-100
9492727
Am J Physiol Renal Physiol. 2004 Sep;287(3):F434-41
15113743
J Urol. 2004 Jul;172(1):27-33
15201731
Urology. 2003 Oct;62(4 Suppl 1):31-8
14550835
World J Urol. 2004 Oct;22(4):244-50
15365750
J Urol. 2001 Jul;166(1):311-7
11435892
Acta Histochem. 2006;108(6):441-5
16962646
Neurourol Urodyn. 2002;21(2):136-41
11857667
Acta Obstet Gynecol Scand. 1998 Jan;77(1):87-94
9492726
J Urol. 2003 Sep;170(3):1027-31
12913764
Eur J Pharmacol. 1997 Mar 19;322(2-3):201-10
9098688
Ann Biomed Eng. 2001 Jan;29(1):26-34
11219505
Int Urogynecol J Pelvic Floor Dysfunct. 2007 Dec;18(12):1453-8
17393052
Int Urogynecol J Pelvic Floor Dysfunct. 2007 Jun;18(6):645-51
17043741
Am J Physiol. 1986 May;250(5 Pt 2):H889-91
3706561
J Urol. 1983 Jun;129(6):1262-4
6133969
Mol Pharmacol. 1995 Apr;47(4):726-9
7723733
Nurs Stand. 2006 May 10-16;20(35):48-54
16722123
J Gastrointest Surg. 2003 May-Jun;7(4):572-582
12763419
Am J Physiol Renal Physiol. 2006 May;290(5):F1127-34
16368741
Naunyn Schmiedebergs Arch Pharmacol. 1997 Aug;356(2):151-8
9272719
J Urol. 2006 Dec;176(6 Pt 1):2711-5
17085201
Neurourol Urodyn. 2008;27(4):353-8
17849481